Embil Pharmaceutical Co. Ltd Report issue

For profit Phase 2 Phase 3
Founded: Istanbul Turkey (1921)
Status: Acquired by Exeltis (2014)

Organization Overview

First Clinical Trial
2008
NCT00741845
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

metronidazole (flagyl) (2 trials)

Drugs in Phase 2 Trials (1)

miconazole (monistat) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Trichomonas Infections (Phase 2)

Trichomonas Vaginitis (Phase 2)

Vaginal Diseases (Phase 3)

Vaginitis (Phase 2)

Vaginosis, Bacterial (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2